Based on ACL’s private hospital segment position in its established states of Western Australia, South Australia, Victoria and the Northern Territory by Patient Episode Initiation.
4.Based on information sourced from Medicare Benefits Schedule Item Statistics Report for Category 6 “Pathology Services”, P10 Patient Episode Initiation, and ACL data for the year ending 30 June 2020. The number of ACCs can be used as an illustrative proxy for community pathology segment position, though is not an accurate reflection of revenue due to various factors including differences in ACC size, medical practice size and location. 3.By number of ACCs as at 1 February 2021 excluding 1 SunDoctors ACC. 2.By number of ACCs as at 1 February 2021 excluding 1 SunDoctors ACC. ACL Footprint 13ġ.Based on information sourced from Medicare Benefits Schedule Item Statistics Report for Category 6 “Pathology Services”, P10 Patient Episode Initiation, and ACL data for the year ending 30 June 2020. Focus on research, innovation and advocacyĪCL has a national footprint of 995 ACCs and 30 clinics to collect patient samples and operates 86 NATA accredited laboratories across Australia.Unified pathology system operating primarily under the ACL brand.Over 90 pathologists and over 500 scientists.86 accredited laboratories 10 including four central laboratories.Primary pathology provider to two of the three largest private hospital groups.Diagnosed approximately 15% of all reported melanomas in Australia in 2020 9.Number three and growing presence in NSW and the ACT 6 and growing presence in QLD.Established position in community pathology 5 across WA, VIC, SA and the NT.One of the largest private hospital pathology businesses nationally 4.Australian Clinical Labs Overview Market position ACL has a growing presence in New South Wales and the Australian Capital Territory 3 and has recently expanded into Queensland. ACL is one of the largest private hospital pathology businesses nationally 1 and in its four established regions of Western Australia, Victoria, South Australia and the Northern Territory, has an equivalent market position in community pathology 2 to Sonic Healthcare and Healius.
ACL is a leading Australian private provider of pathology services.
0 kommentar(er)
